Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53 Suppl 2:ii37–ii50., .
Cellulitis incidence in a defined population. Epidemiol Infect. 2006; 134:293–9., , , et al.
Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20:288–93..
Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A:1454–60., , , et al.
Group A streptococcal necrotizing fasciitis: reducing the risk of unwarranted litigation. Am J Emerg Med. 2005; 23:578–9..
Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol. 2007;46:1036–41., , .
Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002;68:109–16., , , et al.
Necrotising infections of soft tissues–a clinical profile. Eur J Surg. 2002;168:366–71., , , et al.
Necrotizing fasciitis: a plea for early diagnosis and treatment. Mt Sinai J Med. 2001;68:253–61., , .
Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224:672–83., , .
Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10., .
Necrotizing fasciitis–the hazards of delay. J R Soc Med. 1995;88:342P–343P..
Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406., , , et al.
Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2006;27:87–96., .
Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74., , , et al.
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–53., , , et al.
Community-associated MRSA–resistance and virulence converge. N Engl J Med. 2005;352:1485–7..
Klebsiella pneumoniae necrotizing fasciitis and septic arthritis: an appearance in the Western hemisphere. Surg Infect (Larchmt). 2007;8:227–32., , , et al.
Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect. 2005;38:430–5., , , et al.
Four cases of necrotizing fasciitis caused by Klebsiella species. Eur J Clin Microbiol Infect Dis. 2004;23:403–7., , , et al.
Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189:462–6., , .
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108:847–50., , , et al.
Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18–24., , , et al.
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999; 28:800–7., , , et al.
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:333–40., , , et al.
Morbidity related to maternal group B streptococcal infections. Acta Obstet Gynecol Scand. 2006;85:1027–37., , , .
Necrotising fasciitis: a new management algorithm based on clinical classification. Int Wound J. 2004;1:189–98., .
Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg. 2007;119:1803–7., , , et al.
Vibrio vulnificus: did Hippocrates describe a fatal case?Rev Infect Dis. 1988;10:614–15., .
Septicemia and gangrenous change of the legs caused by marine vibrio, V. vulnificus–report of a case. Taiwan Yi Xue Hui Za Zhi. 1987;86:448–51., , , .
Climate change and the emergence of Vibrio vulnificus disease in Israel. Environ Res. 2007;103:390–6., , , et al.
In vivo resuscitation, and virulence towards mice, of viable but nonculturable cells of Vibrio vulnificus. Appl Environ Microbiol. 1995;61:2620–3.,
Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2000;2:177–88., .
Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl Environ Microbiol. 1982;44:1466–70., , ,
Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet. 1999;354:1421–4., , , et al.
Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis. 2007;26:785–92., , , .
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob Agents Chemother. 2005;49:3489– 91., , , et al.